رجوع
نطاق اليوم
KWD 86.34
KWD 88.07
نطاق 52 أسبوعًا
KWD 79.55
KWD 106.33
حجم التداول
8,013,606
متوسط 50 يوم / 200 يوم
KWD 96.83
/
KWD 94.49
الإغلاق السابق
KWD 86.58
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 24.2 | 0.2 |
| P/B | 2.4 | 3.0 |
| ROE % | 9.5 | 3.6 |
| Net Margin % | 13.9 | 3.8 |
| Rev Growth 5Y % | 2.7 | 9.7 |
| D/E | 0.6 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 111.45
+26.8%
Low: KWD 100.00
High: KWD 120.00
مكرر الربحية المستقبلي
15.56
ربحية السهم المستقبلية
KWD 5.65
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
36.16B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 7.77
KWD 7.55 – KWD 7.88
|
45.56B | 3 |
| FY2029 |
KWD 7.14
KWD 6.94 – KWD 7.25
|
43.27B | 3 |
| FY2028 |
KWD 6.54
KWD 5.85 – KWD 7.17
|
40.63B | 9 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-17 | KWD 1.34 | KWD 1.36 | +1.5% |
| 2025-11-18 | KWD 1.31 | KWD 1.36 | +3.8% |
| 2025-08-19 | KWD 1.23 | KWD 1.26 | +2.4% |
| 2025-05-21 | KWD 1.58 | KWD 1.62 | +2.5% |
| 2025-02-18 | KWD 1.36 | KWD 1.39 | +2.2% |
| 2024-11-19 | KWD 1.25 | KWD 1.26 | +0.8% |
| 2024-08-20 | KWD 1.20 | KWD 1.23 | +2.5% |
| 2024-05-23 | KWD 1.45 | KWD 1.46 | +0.7% |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 15, 2025 |
Marinaro Michael
EVP, Pres MedSurg and Americas
|
other | 1,371 | KWD 99.87 | KWD 136,921.77 |
| Dec 15, 2025 |
Wall Brett A.
EVP & Pres Neuroscience
|
other | 439 | KWD 99.87 | KWD 43,842.93 |
| Dec 15, 2025 |
Martha Geoffrey
Chairman and CEO
|
other | 1,564 | KWD 99.87 | KWD 156,196.68 |
| Dec 5, 2025 |
KIIL HARRY SKIP
EVP & President Cardiovascular
|
other | 1,702 | KWD 101.36 | KWD 172,514.72 |
| Nov 20, 2025 |
Blomquist Denise L.
Chief Accounting Officer
|
other | 170 | — | — |
| Nov 19, 2025 |
Smith Gregory L
EVP Global Ops & Supply Chain
|
sell | 30,000 | KWD 101.93 | KWD 3,058,451.26 |
| Aug 25, 2025 |
Jellison William R
Director
|
buy | 2,500 | KWD 92.37 | KWD 230,925.00 |
| Aug 22, 2025 |
Jellison William R
Director
|
buy | 2,500 | KWD 92.73 | KWD 231,825.00 |
| Aug 20, 2025 |
Marinaro Michael
EVP, Pres MedSurg and Americas
|
other | 1,052 | KWD 93.22 | KWD 98,067.44 |
| Jul 31, 2025 |
Smith Gregory L
EVP Global Ops & Supply Chain
|
other | 1,630 | KWD 90.24 | KWD 147,091.20 |
| Jun 3, 2025 |
Blomquist Denise L.
Chief Accounting Officer
|
other | 310 | — | — |
| Apr 29, 2025 |
Lofton Kevin E
Director
|
other | 216 | KWD 84.60 | KWD 18,273.60 |
| Apr 29, 2025 |
Fonseca Lidia
Director
|
other | 216 | KWD 84.60 | KWD 18,273.60 |
| Apr 29, 2025 |
Powell Kendall J
Director
|
other | 216 | KWD 84.60 | KWD 18,273.60 |
| Apr 29, 2025 |
HOGAN RANDALL J
Director
|
other | 216 | KWD 84.60 | KWD 18,273.60 |
| Apr 29, 2025 |
DONNELLY SCOTT C
Director
|
other | 216 | KWD 84.60 | KWD 18,273.60 |
| Apr 28, 2025 |
Lofton Kevin E
Director
|
grant | 2,083 | KWD 84.04 | KWD 175,055.32 |
| Apr 28, 2025 |
Fonseca Lidia
Director
|
grant | 2,083 | KWD 84.04 | KWD 175,055.32 |
| Apr 28, 2025 |
Powell Kendall J
Director
|
grant | 2,083 | KWD 84.04 | KWD 175,055.32 |
| Apr 28, 2025 |
HOGAN RANDALL J
Director
|
grant | 2,083 | KWD 84.04 | KWD 175,055.32 |
Dividend History
7 yr streakYield
0.03%
Payout Ratio
0.77%
Growth (3Y)
1.96%
Growth (5Y)
4.42%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 27, 2026 | Apr 17, 2026 | KWD 0.71 | 3.23% |
| Dec 26, 2025 | Jan 16, 2026 | KWD 0.71 | 2.93% |
| Sep 26, 2025 | Oct 17, 2025 | KWD 0.71 | 2.99% |
| Jun 27, 2025 | Jul 11, 2025 | KWD 0.71 | 3.27% |
| Mar 28, 2025 | Apr 11, 2025 | KWD 0.70 | 3.20% |
| Dec 27, 2024 | Jan 10, 2025 | KWD 0.70 | 3.46% |
| Sep 27, 2024 | Oct 11, 2024 | KWD 0.70 | 3.11% |
| Jun 28, 2024 | Jul 12, 2024 | KWD 0.70 | 3.52% |
| Mar 21, 2024 | Apr 12, 2024 | KWD 0.69 | 3.31% |
| Dec 19, 2023 | Jan 12, 2024 | KWD 0.69 | 3.35% |
| Sep 21, 2023 | Oct 13, 2023 | KWD 0.69 | 3.41% |
| Jun 22, 2023 | Jul 14, 2023 | KWD 0.69 | 3.12% |
| Mar 23, 2023 | Apr 14, 2023 | KWD 0.68 | 3.51% |
| Dec 20, 2022 | Jan 13, 2023 | KWD 0.68 | 3.48% |
| Sep 22, 2022 | Oct 14, 2022 | KWD 0.68 | 3.14% |
| Jun 23, 2022 | Jul 15, 2022 | KWD 0.68 | 2.90% |
| Mar 24, 2022 | Apr 22, 2022 | KWD 0.63 | 2.37% |
| Dec 21, 2021 | Jan 14, 2022 | KWD 0.63 | 2.43% |
| Sep 23, 2021 | Oct 15, 2021 | KWD 0.63 | 1.85% |
| Jun 24, 2021 | Jul 16, 2021 | KWD 0.63 | 1.89% |
النقاط الرئيسية
Revenue grew 2.73% annually over 5 years — modest growth
Earnings grew 26.82% over the past year
Generating 5.19B in free cash flow
PEG of 0.75 suggests growth is underpriced
Cash machine — converts 111.22% of earnings into free cash flow
Capital efficient — spends only 5.54% of revenue on capex
النمو
Revenue Growth (5Y)
2.73%
Revenue (1Y)3.62%
Earnings (1Y)26.82%
FCF Growth (3Y)6.40%
الجودة
Return on Equity
9.49%
ROIC5.84%
Net Margin13.90%
Op. Margin17.76%
الأمان
Debt / Equity
0.59
Current Ratio1.85
Interest Coverage8.17
التقييم
P/E Ratio
24.20
Forward P/E15.56
P/B Ratio2.35
EV/EBITDA23.37
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.62% | Revenue Growth (3Y) | 3.63% |
| Earnings Growth (1Y) | 26.82% | Earnings Growth (3Y) | 11.38% |
| Revenue Growth (5Y) | 2.73% | Earnings Growth (5Y) | 6.63% |
| Profitability | |||
| Revenue (TTM) | 33.54B | Net Income (TTM) | 4.66B |
| ROE | 9.49% | ROA | 5.09% |
| Gross Margin | 65.32% | Operating Margin | 17.76% |
| Net Margin | 13.90% | Free Cash Flow (TTM) | 5.19B |
| ROIC | 5.84% | FCF Growth (3Y) | 6.40% |
| Safety | |||
| Debt / Equity | 0.59 | Current Ratio | 1.85 |
| Interest Coverage | 8.17 | ||
| Dividends | |||
| Dividend Yield | 0.03% | Payout Ratio | 0.77% |
| Dividend Growth (3Y) | 1.96% | Dividend Growth (5Y) | 4.42% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 24.20 | Forward P/E | 15.56 |
| P/B Ratio | 2.35 | P/S Ratio | 3.36 |
| PEG Ratio | 0.75 | Forward PEG | N/A |
| EV/EBITDA | 23.37 | Fwd EV/EBITDA | 13.37 |
| Forward P/S | 3.12 | Fwd Earnings Yield | 6.43% |
| FCF Yield | 4.59% | ||
| Market Cap | 112.84B | Enterprise Value | 139.14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 33.54B | 32.36B | 31.23B | 31.69B | 30.12B |
| Net Income | 4.66B | 3.68B | 3.76B | 5.04B | 3.61B |
| EPS (Diluted) | 3.61 | 2.76 | 2.82 | 3.73 | 2.66 |
| Gross Profit | 21.91B | 21.15B | 20.51B | 21.54B | 19.63B |
| Operating Income | 5.96B | 5.14B | 5.49B | 5.75B | 4.48B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 91.68B | 89.98B | 90.95B | 90.98B | 93.08B |
| Total Liabilities | 43.42B | 39.56B | 39.28B | 38.26B | 41.48B |
| Shareholders' Equity | 48.02B | 50.21B | 51.48B | 52.55B | 51.43B |
| Total Debt | 28.52B | 25.02B | 24.36B | 24.11B | 26.39B |
| Cash & Equivalents | 2.22B | 1.28B | 1.54B | 3.71B | 3.59B |
| Current Assets | 23.81B | 21.94B | 21.68B | 23.06B | 22.55B |
| Current Liabilities | 12.88B | 10.79B | 9.05B | 12.39B | 8.51B |